Biologics Safety Testing Market

Biologics Safety Testing Market is valued at USD 3.95 Billion in 2020 and is expected to reach USD 9.58 Billion by 2027 with a CAGR of 13.5% over the forecast period.

Biologics Safety Testing Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2021-2027– Growing number of drug launches and increasing incidences of chronic diseases are some of the major factors driving the growth of the Global Biologics Safety Testing Market.

Scope of Global Biologics Safety Testing Market Report

Biologics are the large and complex molecules derived from the genes of living organisms by advanced DNA technologies. These are advanced drugs used in the treatment of cancer, rheumatoid arthritis, and other diseases.  These biologics are actively incorporated in the development of new medicines as well as the improvement of existing drugs. Testing the safety of these biologics is critical for avoiding the inadvertent inclusion of unknown entities in the drug manufacturing system. Additionally, biological safety testing is carried by using various tests such as sterility tests, endotoxins tests, residual host contamination detection tests, and bioburden tests among others. However, untested and unsafe biologics can cause greater harm to the global population as drugs derived from them can create new abnormalities for patients, and further complicate their health conditions. Moreover, biologics are products derived from biological sources and used as medicines in humans or animals. Biologics can include viruses, substances derived from blood and serum, toxins, antitoxins, vaccines, and large polypeptides.

Global biologics safety testing market report is segmented on the basis of product type, test type, application, and region & country level. Based upon product type, global biologics safety testing is classified into kits & reagents, services, and instruments. Based upon test type, the market is segmented into endotoxin test, sterility test, cell line authentication, and characterization test, bioburden test, residual host contaminant detection test, adventitious agent detection tests, and another test. Based upon application, the biological safety testing market segmented into vaccine & therapeutics development, blood and blood-related product testing, cellular and gene therapy, tissue, and tissue-related product testing, and stem cell research.

The regions covered in this Biologics safety testing market report are North America, Europe, Asia-Pacific and rest of the World. On the basis of country level, market of biologics safety testing sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Key Players for Biologics Safety Testing

• Charles River Laboratories International, Inc
• Merck KGaA
• Lonza Group Ltd.
• SGS S.A.
• Thermo Fisher Scientific Inc
• Wuxi APPTEC
• Sartorius AG
• Cytovance Biologics, Inc
• Pace Analytical Services Inc
• Toxikon Corporation
• Eurofins Scientific SE
• Avance Biosciences Inc
• Source Bioscience 

Click Here to know more about Companies

Biologics Safety Testing Market Segmentation:

By Product:

• Kits & Reagents
• Services
• Instruments

By Test Type:

• Endotoxin Test
• Sterility Test
• Cell Line Authentication and Characterization Test
• Bioburden Test
• Residual Host Contaminant Detection Test
• Adventitious Agent Detection Tests
• Other Test 

By Application:

• Vaccine & Therapeutics Development
• Blood and Blood-Related Product Testing
• Cellular and Gene Therapy
• Tissue and Tissue-Related Product Testing
• Stem Cell Research

News: -

Eurofins Germany Completed its Testing Portfolio for BioPharmaceuticals

October 4, 2018; through the acquisition of PHAST GmbH, Eurofins BioPharma Product Testing Germany strengthened its service portfolio for the research-oriented biotech and pharmaceutical industries by offering full service testing packages for large and small molecules. Customers now benefit from a complete package of physico-chemical and microbiological tests for raw materials, finished products, APIs and excipients.   

Increasing Drug Launches, Stringent Government Regulations Regarding Biologics are some of the Factors Driving the Market Growth.

Rise in the pharmaceutical and biotechnology industry, huge R&D investment by key players in the life sciences industry, and increase in number of new drug launches in recent years are some of the major factors driving the market growth.  An increase in the number of new biologics by biotechnology and pharmaceutical manufacturers and an increasing base of numerous patients worldwide are also expected to boost the market growth within the forecast period.  For example, according to U.S. National Library of Medicine National Institutes of Health; nearly half approximately 45% or 133 million of all Americans suffer from at least one chronic disease. According to the Centers for Disease Control, in the U.S. alone, chronic diseases account for nearly 75 percent of aggregate healthcare spending or an estimated $5300 per person annually.

However, stringent regulatory requirements and a longer approval time may act as a restraining factor for the market. In spite of that, increasing pharmaceutical outsourcing and technological advancement and increase number of applications are may create more opportunities for the further growth of the market.

North America is expected to Dominate the Global Biologics Safety Testing Market

North America is expected to account for the highest market share of the biologics safety testing market and the region is also expected to dominance over the forecast period due to the increasing prevalence of chronic diseases, growing inclination towards the consumption of biologics safety testing in various applications and presence of key players in this region. For example; in 2018; the research and development (R&D) expenditure of its member companies reached USD 79.6 billion worldwide. The pharmaceutical sector invests more money in R&D than many other industries: PhRMA members spent around 19.5 percent of their combined global revenues on R&D in 2018.

Europe is the second-largest regional market for biologics safety testing owing to the high R&D spending, growing biologics development projects, government support for R&D, and the presence of developed healthcare infrastructure in this region.

Key Benefits for Global Biologics Safety Testing Market Report-

• Global biologics safety testing market report covers in-depth historical and forecasts analysis.
• Global biologics safety testing market research report provides detailed information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country levels.
• Global biologics safety testing market report helps to identify opportunities in the marketplace.
• Global biologics safety testing market report covers extensive analysis of emerging trends and competitive landscape.

Biologics Safety Testing Market Report Coverage

On Special Requirement Pulse Oximeter Market Report is also available for below Regions and Country:

North America

• U.S.
• Canada

Europe

• Germany
• France
• U.K.
• Italy
• Spain
• Sweden
• Netherland
• Turkey
• Switzerland
• Belgium
• Rest of Europe

Asia-Pacific

• South Korea
• Japan
• China
• India
• Australia
• Philippines
• Singapore
• Malaysia
• Thailand
• Indonesia
• Rest Of APAC

Latin America

• Mexico
• Colombia
• Brazil
• Argentina
• Peru
• Rest of South America

Middle East and Africa

• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest Of MEA

Top Other Trending Reports:

• Water Treatment Chemicals Market Size, Share, & Trends Analysis Report 2021-2027
• Microalgae Market Size, Share, Companies & Trends Analysis Report 2021-2027

Frequently Asked Questions (FAQ) :